Immediate Implant in Posterior Mandible Region

WASIM MHD JEHAD HALABI

Status: Not yet enrolling

Conditions: Immediate Implant With Bone Graft

Treatments: Device: Implant

Study type: Interventional

Funder types: Other

Identifiers

NCT07027904

xenograft with (PRF)

Details and patient eligibility

About

This study aims to evaluate implant stability and Width bone after placement of immediate implant and Xenograft mixed with Hyaluronic acid or with Platelet-Rich Fibrin (PRF) at posterior mandible region

Enrollment: 24 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• • Age ≥ 18 years.

  • Both sexes.
  • Cooperative and likely to maintain good dental health.
  • Recent extraction multi roots.
  • There is a bone between (2 or 3) mm at lest from the apex of the root.

Exclusion criteria

• • Patients who had undergone previous extraction of all badly decayed teeth .

  • Implant placement in both healed bone and at the extraction sites in the same procedure.
  • Presence of any local or systemic factors that might contraindicate oral surgery.
  • Poor oral hygiene.
  • Conditions that complicate wound healing such as uncontrolled diabetes, smoking (10 cigarettes a day), pregnancy, a history of drug or alcohol abuse, and an inability or unwillingness to return for follow-ups after occlusal loading.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

24 participants in 2 patient groups

using xenograft as space filling material mixed with hyaluronic acid

Active Comparator group

Description:

the jumping space will packed using Xenograft (cur oss , Astro star) with particle size ranging from 0.25 to 1 mm and it will be mixed with hyaluronic acid

Treatment:

Device: Implant

xenograft (cur oss , Astro star ) mixed with Platelet-Rich Fibrin (PRF)

Experimental group

Description:

the jumping space will packed using Xenograft (cur oss , Astro star) with particle size ranging from 0.25 to 1 mm and it will be mixed with Platelet-rich fibrin (PRF)

Treatment:

Device: Implant